"Vindesine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Vinblastine derivative with antineoplastic activity against CANCER. Major side effects are myelosuppression and neurotoxicity. Vindesine is used extensively in chemotherapy protocols (ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS).
| Descriptor ID |
D014751
|
| MeSH Number(s) |
D03.132.436.681.827.830 D03.633.100.473.402.681.827.830
|
| Concept/Terms |
Vindesine- Vindesine
- Vindesin
- Desacetylvinblastine Amide
|
Below are MeSH descriptors whose meaning is more general than "Vindesine".
Below are MeSH descriptors whose meaning is more specific than "Vindesine".
This graph shows the total number of publications written about "Vindesine" by people in this website by year, and whether "Vindesine" was a major or minor topic of these publications.
![]()
To see the data from this visualization as text,
click here.
Below are the most recent publications written about "Vindesine" by people in Profiles.
-
Cisplatin, gemcitabine, and vinorelbine combination therapy in advanced non-small-cell lung cancer: a phase II randomized study of the Southern Italy Cooperative Oncology Group. J Clin Oncol. 1999 May; 17(5):1526-34.
-
Phase II trial of mitomycin, vindesine, and hexamethylmelamine in metastatic non-small cell bronchogenic carcinoma. Cancer Treat Rep. 1986 Dec; 70(12):1447-8.
-
Vindesine: phase II evaluation in colon cancer and description of its platelet stimulating activity. Cancer Chemother Pharmacol. 1982; 9(1):41-4.
-
Phase II study of vindesine in patients with metastatic breast cancer. Cancer Treat Rep. 1981 Jul-Aug; 65(7-8):659-63.